Bioburden Control within Continuous Manufacturing

Logo
Presented by

Britta Manser, Manager EU SLS Continuous Bioprocessing for Pall Corporation

About this talk

Bioburden control within continuous manufacturing Bioburden control within continuous manufacturing is a key area of concern in the biotech industry. In this short video from Pall Biotech, Britta Manser outlines how existing technologies can help mitigate potential risks linked to bioburden control among new technologies. Do you like the idea of producing 100 g of your mAb product every day? This is now possible using a continuous processing platform. Download a brochure to discover how. http://go.pall.com/brochure-continuousbioprocessing.html?utm_source=biopharma-asia&utm_medium=link&utm_campaign=19-03-121-ISCON&utm_content=brochure

Related topics:

More from this channel

Upcoming talks (28)
On-demand talks (300)
Subscribers (29500)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.